Spyros Papapetropoulos - 10 May 2023 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Director
Signature
/s/ Spyros Papapetropoulos
Issuer symbol
LPCN
Transactions as of
10 May 2023
Net transactions value
+$7,968
Form type
4
Filing time
12 May 2023, 16:37:29 UTC
Previous filing
28 Nov 2022
Next filing
07 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $7,968 +30,000 +94% $0.2656 62,000 10 May 2023 Common Stock 30,000 $0.2656 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% vesting one year from date of grant.